Macro Group Pharmaceuticals (Macro Capital) (MCRO) has postponed its Initial Public Offering (IPO) due to the many IPOs introduced at the same time in the Egyptian Exchange.

The postponed came in coordination with the Financial Regulatory Authority and concerned bodies.  

Integrated Diagnostic Holdings (IDH) is poised to float, however, the trading of Taaleem Management shares started last week.

Macro Capital intended to float a maximum of 264.513 million shares, representing 45.8% of total issued shares.

The pharmaceutical company announced earlier offering its share at EGP 6.15 per each in the secondary market. 

Macro Capital is a cosmeceutical company that was established in 2002. It offers a diversified product range focused on cosmeceuticals and herbal drugs.